CY2021A - Stabilized solutions of platinum (ii) antitumor agents - Google Patents

Stabilized solutions of platinum (ii) antitumor agents

Info

Publication number
CY2021A
CY2021A CY202198A CY202198A CY2021A CY 2021 A CY2021 A CY 2021A CY 202198 A CY202198 A CY 202198A CY 202198 A CY202198 A CY 202198A CY 2021 A CY2021 A CY 2021A
Authority
CY
Cyprus
Prior art keywords
platinum
antitumor agents
solutions
stabilized solutions
oxygen
Prior art date
Application number
CY202198A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22307943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2021(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY2021A publication Critical patent/CY2021A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/282Platinum compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
CY202198A 1993-08-11 1998-02-20 Stabilized solutions of platinum (ii) antitumor agents CY2021A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/105,817 US5455270A (en) 1993-08-11 1993-08-11 Stabilized solutions of platinum(II) antitumor agents

Publications (1)

Publication Number Publication Date
CY2021A true CY2021A (en) 1998-02-20

Family

ID=22307943

Family Applications (1)

Application Number Title Priority Date Filing Date
CY202198A CY2021A (en) 1993-08-11 1998-02-20 Stabilized solutions of platinum (ii) antitumor agents

Country Status (24)

Country Link
US (1) US5455270A (de)
EP (1) EP0642792B1 (de)
JP (1) JP3629044B2 (de)
KR (1) KR100351713B1 (de)
CN (1) CN1082813C (de)
AT (1) ATE152349T1 (de)
AU (1) AU685126B2 (de)
CA (1) CA2128641A1 (de)
CY (1) CY2021A (de)
CZ (1) CZ188494A3 (de)
DE (1) DE69402931T2 (de)
DK (1) DK0642792T3 (de)
ES (1) ES2102743T3 (de)
FI (1) FI113618B (de)
GR (1) GR3024340T3 (de)
HK (1) HK115497A (de)
HU (1) HU220074B (de)
IL (1) IL110577A (de)
NO (1) NO308288B1 (de)
NZ (1) NZ264210A (de)
PL (1) PL178689B1 (de)
RU (1) RU2142797C1 (de)
TW (1) TW383224B (de)
ZA (1) ZA946007B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2989695A (en) * 1994-08-08 2000-03-07 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
TR200002243T2 (tr) * 1997-11-10 2000-12-21 Memorial Sloan-Kettering Cancer Center Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı.
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
CZ292170B6 (cs) * 1998-08-14 2003-08-13 Pliva-Lachema A.S. Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
RU2252022C2 (ru) * 1999-08-30 2005-05-20 Дебиофарм С.А. Стабильный фармацевтический препарат оксалиплатины для парентерального введения
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CN1121380C (zh) * 2000-03-03 2003-09-17 北京兴大豪斯科技有限公司 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物
RU2219183C2 (ru) * 2000-03-03 2003-12-20 Зукин ЯН Производное комплекса удвоенная дикарбоновая кислота-диаминоплатина, способ его получения, противоопухолевая фармацевтическая композиция и использование этого производного
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
DE10032256C2 (de) * 2000-07-03 2003-06-05 Infineon Technologies Ag Chip-ID-Register-Anordnung
KR100363394B1 (ko) * 2000-08-21 2002-12-05 한국과학기술연구원 온도감응성을 갖는 포스파젠삼량체-백금착물 복합체, 그의제조방법 및 그를 함유하는 항암제 조성물
ATE431352T1 (de) * 2001-11-30 2009-05-15 Jingzun Wang Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
FR2841784B1 (fr) * 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
AU2005329764B2 (en) * 2005-03-28 2010-08-12 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (II) antitumour agents
WO2007074641A1 (ja) * 2005-12-29 2007-07-05 Nipro Corporation 白金錯体を含有する水溶液医薬製剤
CN101723982B (zh) * 2008-10-31 2013-01-02 齐鲁制药有限公司 具有抗癌活性的合铂化合物及其合成方法
EP3280408B1 (de) * 2015-04-10 2019-10-23 Syn-Nat Products Enterprise LLC Verfahren zur herstellung von dicycloplatin
AU2016265922B2 (en) * 2015-05-18 2021-05-20 Syn-Nat Products Enterprise LLC A pharmaceutical co-crystal and use thereof
CN105726474B (zh) * 2016-04-12 2018-04-13 周英杰 一种用于治疗晚期卵巢癌的注射液及其制备方法
CN105726475B (zh) * 2016-04-12 2018-05-04 青岛市妇女儿童医院 一种治疗晚期卵巢癌的注射液及其制备方法
CN106188150A (zh) * 2016-04-13 2016-12-07 范如霖 一类碳铂复合物抗癌药及其制备方法和用途
US12427104B1 (en) 2025-04-01 2025-09-30 Ingenus Pharmaceuticals, Llc Injectable carboplatin formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605550A5 (de) * 1972-06-08 1978-09-29 Research Corp
US4657927A (en) * 1978-05-04 1987-04-14 Research Corporation Malonato platinum compounds
CH672109A5 (de) * 1987-01-30 1989-10-31 Wiedmer Plastikform W
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
IL85790A0 (en) * 1988-03-20 1988-09-30 Abic Ltd Solution of carboplatin
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.

Also Published As

Publication number Publication date
FI113618B (fi) 2004-05-31
KR100351713B1 (ko) 2002-12-28
RU94028650A (ru) 1996-11-10
NO942944L (no) 1995-02-13
CN1082813C (zh) 2002-04-17
EP0642792B1 (de) 1997-05-02
CA2128641A1 (en) 1995-02-12
IL110577A0 (en) 1994-11-11
ZA946007B (en) 1995-02-10
HU220074B (hu) 2001-10-28
HUT75154A (en) 1997-04-28
PL304601A1 (en) 1995-02-20
US5455270A (en) 1995-10-03
PL178689B1 (pl) 2000-06-30
FI943666A0 (fi) 1994-08-08
TW383224B (en) 2000-03-01
HU9402307D0 (en) 1994-10-28
ES2102743T3 (es) 1997-08-01
DK0642792T3 (da) 1997-10-20
CN1118252A (zh) 1996-03-13
ATE152349T1 (de) 1997-05-15
IL110577A (en) 2000-06-01
EP0642792A1 (de) 1995-03-15
KR950005305A (ko) 1995-03-20
RU2142797C1 (ru) 1999-12-20
AU685126B2 (en) 1998-01-15
NO942944D0 (no) 1994-08-09
NZ264210A (en) 1995-10-26
HK115497A (en) 1997-08-29
JP3629044B2 (ja) 2005-03-16
AU6898294A (en) 1995-02-23
DE69402931D1 (de) 1997-06-05
CZ188494A3 (en) 1995-02-15
DE69402931T2 (de) 1997-12-18
GR3024340T3 (en) 1997-10-31
NO308288B1 (no) 2000-08-28
JPH0753368A (ja) 1995-02-28
FI943666L (fi) 1995-02-12

Similar Documents

Publication Publication Date Title
CY2021A (en) Stabilized solutions of platinum (ii) antitumor agents
EP1069121A4 (de) Reagenz zum nachweis von singulett-sauerstoff
GR3034822T3 (en) Stabilization of aqueous polymers in the presence of hydroxylamine.
GR3006004T3 (de)
ES2099013A1 (es) Nuevos compuestos de polimetilpiperidina con grupos de silano y su uso como estabilizantes para materiales organicos.
ES8609271A1 (es) Procedimiento para preparar derivados de carbamoilimidazol fungicidas
AU551841B2 (en) Diamide pest control agents
TR21241A (tr) 4 - halo - s*bstit*e edilmis sakaroz t*revleri
SG48485A1 (en) Stabilization of non-halogenated 3-isothiazolones in aggressive systems
ATE166205T1 (de) Tb-wirksame carbonsäure
ES2159262A1 (es) Compuestos aminicos estericamente impedidos.
ZA881430B (de)
AU623986B2 (en) Platinum complexes and antitumor agents containing them as an active ingredient
GB1458063A (en) 4-m,m-di-ti-butyl-p-hydroxyphenyl-butyl-2 compounds
DE59305253D1 (de) Lagerstabile Lösungen von carbonisiertem Magnesiummethylat in Methanol sowie deren Herstellung und Verwendung
HUT42264A (en) Insecticide and acaricide compositions containing benzoyl-carbamide derivatives as active ingredients and process for preparing the active ingredients
EP0657412A4 (de)
DE3469729D1 (en) Process for the stabilisation of perchlorethylene containing cyclohexene oxide
GR82090B (de)
CO4410401A1 (es) Proceso para preparar un producto de organoaluminoxi solido util como catalizador de polimerizacion